Ak Medical Technology Profile
Key Indicators
- Authorised Capital ₹ 3.40 Cr
as on 12-12-2024
- Paid Up Capital ₹ 3.30 Cr
as on 12-12-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -68.38%
(FY 2021)
- Profit 161.63%
(FY 2021)
- Ebitda 95.75%
(FY 2021)
- Net Worth 12.52%
(FY 2021)
- Total Assets -11.68%
(FY 2021)
About Ak Medical Technology
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.40 Cr and a paid-up capital of Rs 3.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kartik Deshpande and Sneha Deshpande serve as directors at the Company.
- CIN/LLPIN
U85100KA2015PTC080554
- Company No.
080554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ak Medical Technology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kartik Deshpande  | Director | 27-May-2015 | Current |
| Sneha Deshpande | Director | 27-May-2015 | Current |
Financial Performance of Ak Medical Technology.
Ak Medical Technology Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 68.38% decrease. The company also saw a substantial improvement in profitability, with a 161.63% increase in profit. The company's net worth Soared by an impressive increase of 12.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ak Medical Technology?
In 2021, Ak Medical Technology had a promoter holding of 43.27% and a public holding of 56.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ak Healthcare Private LimitedActive 11 years 4 months
Kartik Deshpande and Sneha Deshpande are mutual person
- Assisted Medtek Technology Private LimitedActive 11 months 2 days
Sneha Deshpande is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ak Medical Technology?
Ak Medical Technology has a workforce of 28 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ak Medical Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ak Medical Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
